Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD

Lilly claimed success in a head-to-head trial of oral GLP-1 drugs. Elsewhere, Novo planned a new weight loss trial and an AI-focused startup raised its second ‘megaround.’

Abia validates climate policy, prioritises disability inclusion – EnviroNews

February 1, 2026

Credibility of France’s climate leadership on the line as Senate votes to revive oil and gas extraction overseas – EnviroNews

January 31, 2026

Source link

Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD

Abia validates climate policy, prioritises disability inclusion – EnviroNews

Credibility of France’s climate leadership on the line as Senate votes to revive oil and gas extraction overseas – EnviroNews

Inside Trumpworld’s Reality Distortion Field

“Africa Needs More Trade, Not Aid”: ATRN10 Sets Bold Agenda for the Future of Tax Research

“Africa Needs More Trade, Not Aid”: ATRN10 Sets Bold Agenda for the Future of Tax Research

Leave a Reply Cancel reply

RECOMMENDED NEWS

Concerns Grow Over Track Conditions at Usain Bolt Sports Complex

USGS’ biological research arm could vanish next week

Charm offensive: Google’s Gradient backs this startup to bring more pizzazz to the command line

The First Gallery Show Dedicated to Previously Unseen Works Capturing Life Under Colonial Rule in Ghana

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Lilly, Novo showcase new obesity drug data; Fasenra falls short in COPD

Related posts

Inside Trumpworld’s Reality Distortion Field

“Africa Needs More Trade, Not Aid”: ATRN10 Sets Bold Agenda for the Future of Tax Research

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS